Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling

James H M Simon, Eric H J H M Claassen, Carmen E Correa, Albert D M E Osterhaus

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Patent applications that incorporate the genomic sequence of the severe acute respiratory syndrome (SARS) coronavirus, have been filed by a number of organizations. This is likely to result in a fragmentation of intellectual property (IP) rights which in turn may adversely affect the development of products, such as vaccines, to combat SARS. Placing these patent rights into a patent pool to be licensed on a non-exclusive basis may circumvent these difficulties and set a key precedent for the use of this form of mechanism in other areas of health care, leading to benefits to public health.

    Original languageEnglish
    Pages (from-to)707-10
    Number of pages4
    JournalBulletin of the World Health Organization
    Volume83
    Issue number9
    Publication statusPublished - Sep 2005

    Keywords

    • AIDS Vaccines
    • Humans
    • Intellectual Property
    • Patents as Topic
    • Severe Acute Respiratory Syndrome
    • Journal Article
    • Research Support, Non-U.S. Gov't

    Fingerprint Dive into the research topics of 'Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling'. Together they form a unique fingerprint.

    Cite this